Company Filing History:
Years Active: 2002
Title: Kenneth Thomas Smith: Innovator in Papillomavirus Treatment
Introduction
Kenneth Thomas Smith is a notable inventor based in Glasgow, GB. He has made significant contributions to the field of medical research, particularly in the treatment of papillomavirus-related conditions. His innovative work has led to the development of a unique method that holds promise for both prevention and treatment of tumors.
Latest Patents
Kenneth Thomas Smith holds a patent for a method of treatment using papillomavirus L2 protein. This patent, which is particularly focused on BPV-2 and BPV-4, involves the cloning of the L2 protein as a fusion protein with beta-galactosidase and GST. The findings indicate that vaccination of calves using this method has both a prophylactic effect in tumor prevention and a therapeutic effect in tumor regression. He has 1 patent to his name.
Career Highlights
Kenneth is associated with Cancer Research Campaign Technology Limited, where he continues to advance his research and innovations. His work is pivotal in the ongoing fight against cancer, particularly in developing effective treatment methods.
Collaborations
He has collaborated with notable colleagues such as William Fleming Hoggan Jarrett and Maria Saveria Campo, contributing to a collective effort in cancer research and treatment.
Conclusion
Kenneth Thomas Smith's innovative approach to papillomavirus treatment exemplifies the impact of research and development in the medical field. His contributions are vital in paving the way for future advancements in cancer therapy.